Inventor
SHAYMAN JAMES A
US26 patents
⚠️ This page may combine multiple inventors who share the name “SHAYMAN JAMES A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV MICHIGAN
20 patentsUS6051598AApr 18, 2000
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN175 citations99
US6030995AFeb 29, 2000
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN124 citations99
US5952370ASep 14, 1999
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN111 citations99
US5945442AAug 31, 1999
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN112 citations99
US5916911AJun 29, 1999
Amino ceramide--like compounds and therapeutic methods of use
UNIV MICHIGAN146 citations99
US6569889B2May 27, 2003
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN76 citations98
US6255336B1Jul 3, 2001
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN79 citations96
US6040332AMar 21, 2000
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN68 citations96
US5302609AApr 12, 1994
Treatment of diabetic nephropathy
UNIV MICHIGAN73 citations96
US7615573B2Nov 10, 2009
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
UNIV MICHIGAN36 citations95
US6916802B2Jul 12, 2005
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN64 citations95
US6098631AAug 8, 2000
Compositions and methods for treating autoimmune disease
UNIV MICHIGAN51 citations93
US7335681B2Feb 26, 2008
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN26 citations92
US7148251B2Dec 12, 2006
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN38 citations92
US6890949B1May 10, 2005
Amino ceramide-like compounds and therapeutic methods of use
UNIV MICHIGAN41 citations92
US6518259B1Feb 11, 2003
Compositions for treating autoimmune disease
UNIV MICHIGAN14 citations81
US8052970B2Nov 8, 2011
Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
UNIV MICHIGAN6 citations72
US7582442B2Sep 1, 2009
Methods and compositions for using aleveolar macrophage phospholipase A2
UNIV MICHIGAN6 citations72
US7319015B2Jan 15, 2008
Methods and compositions for using alveolar macrophage phospholipase A2
UNIV MICHIGAN4 citations61
US8961959B2Feb 24, 2015
Glucosylceramide synthase inhibitors and therapeutic methods using the same
UNIV MICHIGAN3 citations60
UNIV MICHIGAN REGENTS
3 patentsUS10202340B2Feb 12, 2019
Glucosylceramide synthase inhibitors and therapeutic methods using the same
UNIV MICHIGAN REGENTS3 citations71
US10111937B2Oct 30, 2018
Method of reducing accumulation of intracellular tingible body macrophages
UNIV MICHIGAN REGENTS2 citations71
US11220479B2Jan 11, 2022
Glucosylceramide synthase inhibitors and therapeutic methods using the same
UNIV MICHIGAN REGENTS1 citations60